Our clinical trials

A clinical trial of BLU-667 for non-small cell lung cancer, medullary thyroid cancer and other RET-altered tumors.
A clinical trial of avapritinib for people with advanced systemic mastocytosis.
A clinical trial of avapritinib for people with advanced GIST. This trial is currently enrolling patients who have progressed following first-line treatment with imatinib (Gleevec®).
A clinical trial of avapritinib for people with advanced systemic mastocytosis.
A double-blind clinical trial of avapritinib for people with indolent and smoldering systemic mastocytosis.
A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).